can semaglutide cause kidney damage significant 24% reduction in disease progression and death related to kidney and cardiovascular causes in those treated with compared to a placebo Semaglutide: A Breakthrough for Chronic

Doseresponse effects on HbA(1c) and bodyweight reduction of survodutide, a dual glucagon/GLP- 1 receptor agonist, compared with placebo and open-label semaglutide in people with type 2 diabetes: a randomised clinical trial

A Stanford randomized controlled trial found that a 10-week high-fermented-food diet increased gut microbial diversity and lowered inflammatory markers in healthy adults

She identified the therapy pillars for chronic kidney disease and type 2 diabetes as: SGLT2 inhibitors Glucagon-like peptide-1 (GLP-1) receptor agonists (including semaglutide) Renin-angiotensin system inhibitors mineralocorticoid-receptor antagonists The first two drug classes above lower blood glucose, and the second two classes lower blood pressure, Tuttle said

Funding This trial was funded by Novo Nordisk A/S, Sborg, Denmark